38 results
8-K
EX-10.1
4qc87bjuozrg8u50a2
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-4.1
6dt3g
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
99r4sof
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-10.1
sjhf3tvz
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
S-3
EX-1.2
irl0eoc51 jbph
9 Nov 22
Shelf registration
4:15pm
8-K
EX-10.1
zb6u0zxj5k4x5uttida5
16 Jun 22
Departure of Directors or Certain Officers
7:45am
10-K
EX-10.20
vwp9k003wxen 3wzkkhx
1 Mar 22
Annual report
4:07pm